Maybe this is the answer
Treatment with PBT-2 significantly improved behavioural deficits, biochemical profiles, cellular damage, and curbed the deposition of APP in zinc-induced senescent mice. These findings suggest that PBT-2, acting as a metal-protein attenuating compound, may be helpful in the prevention of AD or alleviation of ageing.
http://link.springer.com/article/10.1007/s10534-016-9922-8
Maybe this is the answer Treatment with PBT-2 significantly...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $12.53K | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13926044 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 153031722 | 56 |
View Market Depth
| Last trade - 14.56pm 19/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |